Who
James A. Bianco
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, TuHURA Biosciences; President and CEO, Cti Biopharma.
In numbers
- Trades disclosed
- 180
- Buys
- 3
- Sells
- 79
- Bought
- $118K
- Sold
- $9.8M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 3 Jan 2006
- Last trade
- 28 May 2026
- Last filed
- 29 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 May 2026filed 29 May 2026 | HURA TuHURA BiosciencesBiotechnology | SEC FORM 4 Code G | —150,000 at $0.00 | filing |
| 28 May 2026filed 29 May 2026 | HURA TuHURA BiosciencesBiotechnology | SEC FORM 4 Code G | —150,000 at $0.00 | filing |
| 6 Jan 2026filed 8 Jan 2026 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —610,332 at $0.00 | filing |
| 6 Jan 2026filed 8 Jan 2026 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —610,332 at $0.00 | filing |
| 12 Dec 2025filed 17 Dec 2025 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,414,891 at $0.00 | filing |
| 12 Nov 2024filed 14 Nov 2024 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,065,990 at $0.00 | filing |
| 18 Oct 2024filed 22 Oct 2024 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —357,800 at $0.00 | filing |
| 18 Oct 2024filed 22 Oct 2024 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —71,560 at $0.00 | filing |
| 18 Oct 2024filed 22 Oct 2024 | HURA TuHURA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —191,280 at $0.00 | filing |
| 18 Oct 2024filed 22 Oct 2024 | HURA TuHURA BiosciencesBiotechnology | SEC FORM 4 Code A | —2,323,307 at $0.00 | filing |
| 2 Oct 2016filed 3 Oct 2016 | Cti Biopharmaoption or derivative | SEC FORM 4 Code A | —2,000,000 at $0.00 | filing |
| 2 Oct 2016filed 3 Oct 2016 | Cti Biopharmaoption or derivative | SEC FORM 4 Code A | —4,539,290 at $0.00 | filing |
| 24 Jun 2016filed 24 Jun 2016 | Cti Biopharma | SEC FORM 4 Sold | $3,70010,000 at $0.37 | filing |
| 27 May 2016filed 27 May 2016 | Cti Biopharma | SEC FORM 4 Sold | $4,50010,000 at $0.45 | filing |
| 18 May 2016filed 20 May 2016 | Cti Biopharmaoption or derivative | SEC FORM 4 Code A | —600,000 at $0.00 | filing |
| 29 Apr 2016filed 29 Apr 2016 | Cti Biopharma | SEC FORM 4 Sold | $5,20010,000 at $0.52 | filing |
| 28 Mar 2016filed 30 Mar 2016 | Cti Biopharma | SEC FORM 4 Sold | $4,90010,000 at $0.49 | filing |
| 21 Mar 2016filed 23 Mar 2016 | Cti Biopharma | SEC FORM 4 Sold | $175K318,169 at $0.55 | filing |
| 26 Feb 2016filed 26 Feb 2016 | Cti Biopharma | SEC FORM 4 Sold | $6,30010,000 at $0.63 | filing |
| 16 Feb 2016filed 18 Feb 2016 | Cti Biopharma | SEC FORM 4 Sold | $42K100,000 at $0.42 | filing |
News
No headline names them, or the companies they trade most, lately.